美國和西歐的白內障治療藥市場(2023年):2022年～2028年的各地區分析

本報告提供美國和西歐的白內障治療藥市場相關調查，市場概要，以及今後5年的市場效能預測，平均銷售價格，未來趨勢等資訊。

目錄

• 白內障的罹患率與白內障手術相關資訊
• 美國和西歐白內障手術數量預測(5年預測)
• 晶體存在式人工水晶體和屈光矯正鏡頭的替換方法相關的考察
• 白內障手術使用的抗生素的銷售額預測
• 白內障手術使用的散瞳劑和睫狀肌調節劑的銷售額預測
• 白內障手術使用的抗發炎劑，止痛藥的銷售額預測
• 美國和西歐白內障及白內障/屈光矯正手術的外科醫生的簡介
• 企業的手術供應商相關資訊
• 目前償付水準相關的討論
• 開發中的新關於此產品的說明

What's New:

The second-edition "2023 US and Western Europe Cataract Pharmaceuticals Market Report" features new survey data and forecasts for the United States and Western European markets for cataract pharmaceuticals. The new data explore surgeon preferences for preventing infection, dilation, and managing inflammation and pain. The report now provides the market shares of leading competitors, analyzes pharmaceutical use in the United States by providers' surgical volume, and studies the developmental pipeline for drugs and drug delivery.

The "2023 US and Western Europe Cataract Pharmaceuticals Market Report" offers an in-depth examination of the current cataract pharmaceuticals market in the United States and forecasts market performance over the next five years. The report analyzes the current market and forecasts units, average sales price, and revenue through 2028 by product category. It analyzes products currently on the market and examines the development pipeline, discusses the popularity of intracameral injections and fixed combination eye drops, and analyzes the roles of brand name medications, generics, and compounded formulations.

This comprehensive report covers the United States and Western European markets and provides:

• Information on cataract incidence and cataract surgeries.

• Current estimates and five-year forecasts for cataract surgery volumes in the United States and Western Europe.

• Discussion of phakic and refractive lens exchange procedures.

• Forecasts for sales of antibiotics used in association with cataract surgery.

• Forecasts for sales of mydriatics and cycloplegics used in cataract surgery.

• Forecasts for sales of anti-inflammatory drugs and painkillers used in association with cataract surgery.

• Profile of cataract and cataract/refractive surgeons in the United States and Western Europe

• Information on corporate surgery providers.

• Discussion of current reimbursement levels.

• Descriptions of new products in development.

Author Profile:

Peter Downs

Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.

Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.

In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives, the firm's monthly industry newsletter.